Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

BACKGROUND: In the PATHWAY-2 study of resistant hypertension, spironolactone reduced blood pressure substantially more than conventional antihypertensive drugs. We did three substudies to assess the mechanisms underlying this superiority and the pathogenesis of resistant hypertension. METHODS: PATHW...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet Diabetes Endocrinol
Main Authors: Williams, Bryan, MacDonald, Thomas M, Morant, Steve V, Webb, David J, Sever, Peter, McInnes, Gordon T, Ford, Ian, Cruickshank, J Kennedy, Caulfield, Mark J, Padmanabhan, Sandosh, Mackenzie, Isla S, Salsbury, Jackie, Brown, Morris J
Format: Artigo
Jezik:Inglês
Izdano: The Lancet, Diabetes & Endocrinology 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5966620/
https://ncbi.nlm.nih.gov/pubmed/29655877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(18)30071-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki